Worried about me-too drugs? The medicalization of human variability in order to medicate them into compliance and/or sell them quack cures of dubious value? Ever-rising prices for brand name drugs pushing seniors into penury?Well, you can breathe a (slight) sigh of relief. For the first time ever last year, the global drug industry cut its R&D spending. The trend is expected to continue, at least in the near term.
If you’ll excuse me, the rest of us will be over here in the corner, freaking out a little bit.
Read the rest of this article at The Atlantic.
From TheAtlantic – shaping the national debate on the most critical issues of our times, from politics, business, and the economy, to technology, arts, and culture.
NOW WATCH: Briefing videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.